GE HealthCare Technologies Gross Profit 2020-2023 | GEHC
- GE HealthCare Technologies gross profit for the quarter ending December 31, 2023 was $2.156B, a 11.59% increase year-over-year.
- GE HealthCare Technologies gross profit for the twelve months ending December 31, 2023 was $7.922B, a 10.35% increase year-over-year.
- GE HealthCare Technologies annual gross profit for 2023 was $7.922B, a 10.35% increase from 2022.
- GE HealthCare Technologies annual gross profit for 2022 was $7.179B, a 0.07% increase from 2021.
- GE HealthCare Technologies annual gross profit for 2021 was $7.174B, a 6.01% increase from 2020.
GE HealthCare Technologies Annual Gross Profit (Millions of US $) |
|
---|---|
2023 | $7,922 |
2022 | $7,179 |
2021 | $7,174 |
2020 | $6,767 |
2019 | $6,548 |
GE HealthCare Technologies Quarterly Gross Profit (Millions of US $) |
|
---|---|
2023-12-31 | $2,156 |
2023-09-30 | $1,935 |
2023-06-30 | $1,940 |
2023-03-31 | $1,891 |
2022-12-31 | $1,932 |
2022-09-30 | $1,773 |
2022-06-30 | $1,796 |
2022-03-31 | $1,678 |
2021-12-31 | |
2021-09-30 | |
2020-12-31 | |
2019-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $36.275B | $19.552B |
Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
Axonics (AXNX) | United States | $3.433B | 0.00 |
10x Genomics (TXG) | United States | $3.275B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.194B | 0.00 |
Azenta (AZTA) | United States | $2.979B | 242.82 |
Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
Enovis (ENOV) | United States | $2.812B | 20.84 |
Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
Privia Health (PRVA) | United States | $2.224B | 98.63 |
Schrodinger (SDGR) | United States | $1.712B | 0.00 |
Omnicell (OMCL) | United States | $1.384B | 47.83 |
Phreesia (PHR) | United States | $1.259B | 0.00 |
Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
Standard BioTools (LAB) | United States | $0.728B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
Talkspace (TALK) | United States | $0.538B | 0.00 |
Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
Pulmonx (LUNG) | United States | $0.378B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
American Well (AMWL) | United States | $0.165B | 0.00 |
Outset Medical (OM) | United States | $0.162B | 0.00 |
Augmedix (AUGX) | United States | $0.133B | 0.00 |
MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
TruBridge (TBRG) | United States | $0.125B | 5.33 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
111 (YI) | China | $0.096B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
Zepp Health (ZEPP) | China | $0.053B | 0.00 |
Movano (MOVE) | United States | $0.046B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |